Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Azathioprine toxicity and thiopurine methyltransferase genotype in renal transplant patients.

Transplantation proceedings - 1 Aug 2002

Pandya B, Thomson W, Poulton K, Bruce I, Payne D, Qasim F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azathioprine
Share to Follow-Up Studies
Share to Genotype
Share to Immunosuppressive Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney Transplantation

Share to Methyltransferases

Share to Time Factors

Source

Identifiers

PMID: 12176518
DOI: 10.1016/s0041-1345(02)02963-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Azathioprine toxicity and thiopurine methyltransferase genotype in renal transplant patients.PMID 12176518Read ↗

TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.Semantic proximity Read ↗

Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.Semantic proximity Read ↗

Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).Semantic proximity Read ↗

Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.Semantic proximity Read ↗

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.Semantic proximity Read ↗

Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.Semantic proximity Read ↗

Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients.Semantic proximity Read ↗

Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.Semantic proximity Read ↗

6-Mercaptopurine pharmacokinetics after use of azathioprine in renal transplant recipients with intermediate or high thiopurine methyl transferase activity phenotype.Semantic proximity Read ↗

Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine TherapySemantic proximity Read ↗

The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.